K2X Technology & Life Science, Inc.
KBPH
OTC PK
| 12/31/2021 | 09/30/2021 | 06/30/2021 | 03/31/2021 | 12/31/2020 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 12.76M | 10.76M | 8.62M | 8.26M | 6.45M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | 230.40K | 170.90K | 169.90K | 36.40K |
| Total Current Assets | 12.76M | 10.99M | 8.79M | 8.43M | 6.48M |
|
|
|||||
| Total Current Assets | 12.76M | 10.99M | 8.79M | 8.43M | 6.48M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 293.60K | -- | -- | -- | -- |
| Total Assets | 13.06M | 10.99M | 8.79M | 8.43M | 6.48M |
|
|
|||||
| Total Accounts Payable | 63.70K | 84.50K | 183.00K | 193.10K | 75.10K |
| Total Accrued Expenses | 83.00K | 87.00K | 72.20K | 51.40K | -- |
| Short-term Debt | -- | -- | -- | -- | 8.00K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 146.70K | 171.50K | 255.20K | 244.60K | 83.10K |
|
|
|||||
| Total Current Liabilities | 146.70K | 171.50K | 255.20K | 244.60K | 83.10K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | 8.00K |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | 1.19M | -- |
| Total Liabilities | 146.70K | 171.50K | 255.20K | 1.44M | 83.10K |
|
|
|||||
| Common Stock & APIC | 44.76M | 43.01M | 41.74M | 39.87M | 39.44M |
| Retained Earnings | -31.97M | -32.29M | -33.29M | -32.96M | -33.11M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 12.79M | 10.72M | 8.45M | 6.91M | 6.33M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 122.90K | 101.10K | 85.20K | 78.30K | 72.90K |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 122.90K | 101.10K | 85.20K | 78.30K | 72.90K |
|
|
|||||
| Total Common Equity | 12.79M | 10.72M | 8.45M | 6.91M | 6.33M |
| Total Preferred Equity | 122.90K | 101.10K | 85.20K | 78.30K | 72.90K |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 12.91M | 10.82M | 8.54M | 6.99M | 6.40M |
|
|
|||||
